Treatment with mesoridazine and thioridazine in chronic schizophrenia: I. Assessment of clinical and electrophysiologic responses in refractory hallucinating schizophrenics.
D000328:Adult; D001288:Attention / Q000187:drug effects; D002908:Chronic Disease; D003265:Contingent Negative Variation; D004585:Electrooculography; D005260:Female; D006212:Hallucinations / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008653:Mesoridazine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012890:Sleep / Q000187:drug effects; D013881:Thioridazine / Q000009:adverse effects / Q000627:therapeutic use*
D008653:Mesoridazine; D013881:Thioridazine